

Learn about Vtama (Tapinarof) side effects, from common reactions like folliculitis to serious warnings. Know what's normal and when to contact your doctor.
Starting a new medication always comes with questions — especially about side effects. If your doctor has prescribed Vtama (Tapinarof) cream for plaque psoriasis or atopic dermatitis, here's what the clinical data shows about what you might experience and when you should reach out to your doctor.
Vtama is a first-in-class topical cream that contains Tapinarof 1%. It works by activating the aryl hydrocarbon receptor (AhR) in your skin, which helps reduce inflammation and support your skin barrier. It's FDA-approved for plaque psoriasis in adults and atopic dermatitis in adults and children ages 2 and older.
Unlike topical steroids, Vtama is not a corticosteroid, so it doesn't carry the same risks of skin thinning with long-term use. You can learn more about how Vtama works in our detailed guide.
The following side effects were reported in clinical trials and are listed in Vtama's FDA-approved labeling:
Most of these side effects are mild to moderate and tend to improve as your body adjusts to the medication over the first few weeks.
It's common to experience some folliculitis or mild irritation when you first start Vtama. This doesn't necessarily mean the medication isn't working or that you need to stop. Many patients find these effects lessen after 2–4 weeks of consistent use.
Serious side effects with Vtama are uncommon, but they can happen:
Vtama does not carry a boxed warning (the FDA's most serious warning level). It also does not carry the same risks as topical corticosteroids, such as skin atrophy (thinning), striae (stretch marks), or hypothalamic-pituitary-adrenal (HPA) axis suppression.
There is no adequate data on Vtama use during pregnancy. The prescribing information recommends using it only if the potential benefit justifies the potential risk. There is also no data on whether Tapinarof passes into breast milk. Talk to your doctor if you are pregnant, planning to become pregnant, or breastfeeding.
Vtama is approved for atopic dermatitis in children ages 2 and older. It has not been studied in children under 2 years old and is not approved for pediatric psoriasis. Side effects in children were similar to those seen in adults.
Clinical trials showed no overall differences in safety or effectiveness in patients 65 and older compared to younger adults.
Here are some practical tips for dealing with Vtama's most common side effects:
Contact your doctor if you experience:
Most people who use Vtama tolerate it well. The most common side effects — folliculitis and mild skin irritation — are usually manageable and tend to improve with continued use. Serious reactions are rare.
If you're weighing whether to start Vtama, talk to your dermatologist about what to expect. And when you're ready to fill your prescription, Medfinder can help you find a pharmacy with Vtama in stock.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.